Literature DB >> 9451726

The effect of acute and chronic lithium on forskolin-induced reduction of rat activity.

Y Bersudsky1, Y Patishi, J Bitsch Jensen, A Mørk, O Kofman, R H Belmaker.   

Abstract

Forskolin is a diterpene derivative that activates adenylate cyclase and raises cAMP levels in the cell. Both i.p. and i.c.v. forskolin cause behavioral hypoactivity. Lithium has been reported for many years to block cAMP accumulation, but the behavioral relevance of this biochemical effect is not clear. We studied the effect of acute and chronic lithium on icv forskolin-induced hypoactivity. Acute lithium had no effect, but chronic lithium significantly blocked forskolin-induced hypoactivity. The effect of chronic lithium occurred with both forskolin in DMSO and with a water-soluble forskolin derivative. These results suggest that this behavioral model can be used to investigate whether new inhibitors of adenylate cyclase possess lithium-like effects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9451726     DOI: 10.1007/BF01285562

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  34 in total

1.  Lithium inhibition of adrenaline-stimulated adenylate cyclase in humans.

Authors:  R Ebstein; R Belmaker; L Grunhaus; R Rimon
Journal:  Nature       Date:  1976-02-05       Impact factor: 49.962

2.  Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex.

Authors:  S Avissar; G Schreiber; A Danon; R H Belmaker
Journal:  Nature       Date:  1988-02-04       Impact factor: 49.962

3.  Effects of forskolin on spontaneous behavior, rectal temperature and brain cAMP levels of rats: interaction with rolipram.

Authors:  H Wachtel; P A Löschmann; H H Schneider; K J Rettig
Journal:  Neurosci Lett       Date:  1987-05-06       Impact factor: 3.046

4.  Behavioral and receptor binding studies of phencyclidine (PCP) and lithium interaction in the rat.

Authors:  A Mattia; E E el-Fakahany; J E Moreton
Journal:  Life Sci       Date:  1986-03-17       Impact factor: 5.037

5.  Adenosine receptors of human leukocytes--II. Characterization of an inhibitory P-site.

Authors:  G Marone; R Petracca; S Vigorita; V Casolaro
Journal:  Biochem Pharmacol       Date:  1990-11-01       Impact factor: 5.858

6.  A preliminary study of possible psychoactive effects of intravenous forskolin in depressed and schizophrenic patients. Short communication.

Authors:  Y Bersudsky; M Kotler; M Shifrin; R H Belmaker
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

7.  Cyclic nucleotides in mental disorder.

Authors:  R H Belmaker; J Zohar; R P Ebstein
Journal:  Adv Cyclic Nucleotide Res       Date:  1980

8.  Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxin.

Authors:  D J Dooley; E Mogilnicka; A Delini-Stula; F Waechter; A Truog; J Wood
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Lithium inhibition of forskolin-stimulated adenylate cyclase.

Authors:  P H Andersen; A Geisler
Journal:  Neuropsychobiology       Date:  1984       Impact factor: 2.328

10.  Effect of chronic lithium administration on adrenoceptor binding and adrenoceptor regulation in rat cerebral cortex.

Authors:  G Gross; C Dodt; G Hanft
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-03       Impact factor: 3.000

View more
  1 in total

1.  A preliminary study of possible psychoactive effects of intravenous forskolin in depressed and schizophrenic patients. Short communication.

Authors:  Y Bersudsky; M Kotler; M Shifrin; R H Belmaker
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.